About Technology Issues FAQ

Links

Official Page

A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.